NovoCure

$199.46
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$4.62 (+2.37%) As of 5:02 PM UTC today

Why Robinhood?

You can buy or sell NovoCure and other stocks, options, and ETFs commission-free!

About NVCR

NovoCure Limited Ordinary Shares, also called NovoCure, is called the Tumor Treating Field which used electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St.

CEO

Asaf Danziger

Employees

1,023

Headquarters

St. Helier, Jersey

Founded

2000

Market Cap

21.28B

Price-Earnings Ratio

1.05K

Dividend Yield

—

Average Volume

2.66M

High Today

$203.22

Low Today

$193.04

Open Price

$194.83

Volume

590.48K

52 Week High

$218.09

52 Week Low

$55.40

Analyst Ratings

33%

of 9 ratings

Buy

33%

Hold

56%

Sell

11%

NVCR Earnings

-$0.05

$0.01

$0.06

$0.12

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Available Apr 29, Pre-Market